WeVote
Log In

Bill

Bill

SB 66

Medical Cannabis Pharmacy License Amendments

2026 General Session Introduced by Jen Dailey-Provost and 1 co-sponsor

SB 66 modifies Utah medical cannabis pharmacy licensing requirements, advancing through legislature with favorable committee recommendations to clarify or streamline dispensary operations.

House Comm - Consent Calendar Recommendation [House Natural Resources, Agriculture, and Environment Committee]
#administrativerulemaking #administrativerulemakingandprocedures #agriculture #agriculture&food #controlledsubstances #healthandhumanservices #medicalcannabis #newrulemakingauthority
0
WeVote Research Nonpartisan
Bill Summary · SB 66

Legislative bill overview

SB 66 amends Utah's medical cannabis licensing framework to modify requirements for pharmacy licenses dispensing cannabis products. The bill has passed the Senate and received favorable recommendations from the House Natural Resources, Agriculture, and Environment Committee. Specific amendments appear focused on streamlining licensing procedures or eligibility criteria for medical cannabis pharmacies.

Why is this important

Medical cannabis licensing directly affects patient access, product availability, and regulatory oversight in Utah's medical cannabis program. Changes to pharmacy licensing requirements can either expand patient access by reducing barriers to dispensary operation or strengthen regulatory controls depending on the nature of the amendments. This represents ongoing legislative fine-tuning of Utah's relatively established medical cannabis framework.

Potential points of contention

  • Pharmacy eligibility standards – Clarification or relaxation of licensing requirements could favor certain applicants while potentially raising concerns about regulatory rigor or competitive fairness
  • Implementation timeline – New licensing procedures may create administrative burden or delays for existing pharmacies or new applicants
  • Patient access vs. regulation balance – Supporters may argue amendments improve access; opponents may contend they weaken oversight of product quality and dispensing practices

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.